Despite active investigation of copolymer-1 (Cop-1) for nearly 40 years the mechanisms underlying its neuroprotective properties remain contentious. Nonetheless, current dogma for Cop-1 neuroprotective activities in autoimmune and neurodegenerative diseases include bystander suppression of autoimmune T cells and attenuation of microglial responses. In this report, we demonstrate that Cop-1 interacts directly with primary human neurons and decreases neuronal cell death induced by staurosporine or oxidative stress. This neuroprotection is mediated through protein kinase Ca and brainderived neurotrophic factor. Dendritic cells (DC) uptake Cop-1, deliver it to the injury site, and release it in an active form. Interactions between Cop-1 and DC enhance DC blood brain barrier migration. In a rat model with optic nerve crush injury, Cop-1-primed DC induce T cell independent neuroprotection. These findings may facilitate the development of neuroprotective approaches using DC-mediated Cop-1 delivery to diseased nervous tissue.
IntroductionCopolymer-1 (Cop-1) was developed to mimic the encephalitogenic epitope of myelin basic protein (MBP). However, when administered in complete Freund's adjuvant it failed to induce experimental autoimmune encephalitis (EAE). Surprisingly, Cop-1 suppressed EAE when administered with MBP [1][2][3][4]. These observations led to the development of Cop-1 as a treatment for relapsing-remitting multiple sclerosis [5][6][7][8]. Over the past three decades, scientists have tried to determine how Cop-1 exerts its therapeutic effects [2,4,9,10]. Cop-1-specific T cells partially cross-react with MBP, leading to the secretion of neurotrophic and antiinflammatory factors such as brain derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor, [11][12][13]. [17], and experimentally induced encephalitis [18]. The mechanism(s) underlying Cop-1-induced neuroprotection were attributed to T cells. T cells modulate microglial and astrocyte responses and as such attenuate toxic inflammatory activities and neurodegeneration [11,12,19]. Indeed, the mechanism underlying T cellinduced neuroprotection is linked to modulation of microglial function [20] and increased production of neurotrophins at the site of injury [11,12]. After central nervous system (CNS) injury microglia commonly display a neurotoxic phenotype with local production of glutamate and increased expression of nitric oxide synthase (iNOS), pro-inflammatory cytokines, quinolinic acid and arachidonic acid and its metabolites [21,22]. T cells can induce a neuroprotective microglial phenotype [20].Under certain conditions with progressive neurodegeneration the Cop-1 neuroprotective response is seen before an adaptive immune response is generated [15,17,23], suggesting that Cop-1 induced neuroprotection may be, at least in part, T cell independent. We now demonstrate that Cop-1 treatment of primary human neurons intoxicated with staurosporine or reactiveoxygen species significantly decreases cell death. This neuroprotection is associ...